NCOA4 and pancreatic neoplasm: Mechanistically, ROS induce NCOA4-dependent ferritinophagy and exacerbate mitochondrial and DNA damage, thereby increasing the sensitivity of human pancreatic cancer cells and tumor-bearing mice to chemotherapeutic agents [293].